Sichuan Hebang Biotechnology Co.,Ltd.’s Net Profit Rose 70.2% in First Three Quarters of 2022

Sichuan Hebang Biotechnology Co.,Ltd. (四川和邦生物科技股份有限公司) (603077.SH) reported a net profit of 3.4 billion yuan in the first three quarters of 2022, up 70.2% year-on-year.

Meanwhile, the company posted 10.5 billion yuan in revenue, up 47.2% year-on-year.

At the end of the reporting period, it had 23 billion yuan in total assets and 3.9 billion yuan in total liabilities, with a liability-to-asset ratio of 16.8%.